This is the first time the EMA and AMA have collaborated on a public health emergency since the AMA’s inception.
The US Food and Drug Administration (FDA) is more likely to approve drugs with an orphan designation that were indicated for ...
The EMA’s CHMP delivered two positive opinions, which will likely see an expansion of Novo Nordisk’s Wegovy offerings in Europe.